Hikma Pharmaceuticals and Vistry directors buy while GlobalData CFO sells | Directors Deals
Hikma chair spends £3.5 million Vistry chair backs builder GlobalData CFO raises cash Mazen Darwazah, executive chairman of drug manufacturer Hikma Pharmaceuticals (HIK), bought 200,000 shares at £17.56 for a total value of £3.5 million on 7 August. Darwazah's purchase comes after the company's core first-half operating profit fell by 7% to $373 million 'reflecting evolving product mix and...